Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Litigation Settlement Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LitigationSettlementExpense.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales (excluding amortization of in-licensed rights) | 149,385 | 152,558 | 258,153 | 290,122 |
| Research and development | 91,258 | 204,392 | 245,218 | 977,840 |
| Selling, general and administrative | 107,600 | 137,897 | 216,551 | 271,526 |
| Litigation contingency charge | 39,000 | — | 39,000 | — |
| Amortization of in-licensed rights | 717 | 667 | 1,408 | 1,268 |
| Total cost and expenses | 387,960 | 495,514 | 760,330 | 1,540,756 |
| Operating income (loss) | 13,291 | 115,577 | 371,724 | (184,809) |
| Other (loss) income, net: |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — litigation settlement expense?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — litigation settlement expense of $39M in Q2 2026.
- What does business segments — litigation settlement expense mean?
- This metric represents non-recurring costs associated with legal settlements, judgments, or related litigation expenses incurred within the company's 'All Other Segments' reporting unit. It captures financial outflows that fall outside of core operational activities and are typically excluded from adjusted earnings metrics. Monitoring this figure helps investors assess the impact of legal contingencies on the segment's overall profitability and cash flow profile.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — litigation settlement expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude